pyrvinium has been researched along with Bilateral Wilms Tumor in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Clark, PE; Lee, E; Love, HD; Moses, HL; Polosukhina, D; Zent, R | 1 |
1 other study(ies) available for pyrvinium and Bilateral Wilms Tumor
| Article | Year |
|---|---|
Pharmacologic Inhibition of β-Catenin With Pyrvinium Inhibits Murine and Human Models of Wilms Tumor.
Topics: Animals; Anthelmintics; beta Catenin; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Humans; Mice; Pyrvinium Compounds; Signal Transduction; Transcription, Genetic; Wilms Tumor; Wnt Signaling Pathway | 2017 |